Abbisko Cayman Limited ( 2256.HK) - Key Metrics
2256.HK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | HK$0.48 | HK$0.25 | HK$0.24 | HK$0.23 |
| 2025Q1 | HK$0.48 | HK$0.25 | HK$0.24 | HK$0.23 |
| 2024Q4 | HK$0.01 | -HK$0.14 | -HK$0.14 | -HK$0.14 |
| 2024Q3 | HK$0.01 | -HK$0.14 | -HK$0.14 | -HK$0.14 |
| 2024Q2 | HK$0.38 | HK$0.16 | HK$0.12 | HK$0.12 |
2256.HK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | 9.14 |
| 2025Q1 | ? | 7.75 |
| 2024Q4 | ? | -7.61 |
| 2024Q3 | ? | -6.14 |
| 2024Q2 | ? | 4.66 |
2256.HK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | 2.51% | ? |
| 2025Q1 | 2.96% | ? |
| 2024Q4 | -3.22% | ? |
| 2024Q3 | -4.00% | ? |
| 2024Q2 | 4.10% | ? |
2256.HK
Price: HK$9
52 week price:
Earnings Per Share: 0.26 HKD
P/E Ratio: 42.88
Exchange: HKG
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.4 billion